USPTO serial 77767342
USHSTAT
Reviewed by CopyMark Law Group
Reg. 4014320Status 710
- Filing date
- Status date
- Registration date
- Aug 23, 2011
- Examiner
- EINSTEIN, MATTHEW T
- Law office
- —
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with USHSTAT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Roberta S. Bren
Roberta S. Bren MUNCY, GEISSLER, OLDS & LOWE, P.C.4000 Legato Road, Suite 310Fairfax, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzymes for scientific and research purposes; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research; chemical reagents for use in medical science | SECTION 8 - CANCELLED | — |
| 005 | Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, all for medical purposes; nucleic acid sequences and chemical reagents for medical purposes, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations | SECTION 8 - CANCELLED | — |
| 010 | Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances; syringes and injectors for medical purposes | SECTION 8 - CANCELLED | — |
| 042 | Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology; advisory services relating to research and development of gene therapy products | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford BioMedica Plc
- Other trademarks owned by Oxford BioMedica Plc
- Other trademarks owned by Oxford BioMedica Plc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named USHSTAT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 30, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 23, 2016 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 14, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 14, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 15, 2011 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 9, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 7, 2011 | AMD7 | SEC 7 REQUEST FILED | — |
| Sep 7, 2011 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Aug 23, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 14, 2011 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jul 11, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 8, 2011 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 8, 2011 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Mar 15, 2011 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 18, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 18, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 15, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 14, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 14, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 14, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 14, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 14, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 18, 2010 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 18, 2010 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 18, 2010 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 1, 2010 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 26, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 26, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 26, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 26, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 26, 2010 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 21, 2010 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 10, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 10, 2010 | ALIE | ASSIGNED TO LIE | — |
| Apr 29, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2010 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 7, 2010 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 7, 2010 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 7, 2010 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 17, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 17, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 17, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 27, 2009 | NWAP | NEW APPLICATION ENTERED | — |